JP TSE 4884 Pharmaceutical

Kringle Pharma,Inc.

クリングルファーマ株式会社

Fiscal year ends
Sep
Latest results
FY ending Sep 2025
Employees
17
Revenue
¥72.2M
≈ $458K
Net income
−¥916M
≈ −$5.8M
Total assets
¥2.1B
≈ $13.2M
Equity ratio
63.0%
 

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal yearRevenueNet incomeTotal assetsNet assetsEquity ratioSource
Sep 2025¥72.2M−¥916M ¥2.1B¥1.3B63.0% EDINET
Sep 2024¥80.0M−¥756M ¥2.8B¥2.1B76.5% EDINET
Sep 2023¥69.2M−¥854M ¥2.6B¥2.0B77.2% EDINET
Sep 2022¥392M−¥332M ¥3.2B¥2.8B86.9% EDINET
Sep 2021¥290M−¥301M ¥2.6B¥2.5B95.1% EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings